在血液性恶性瘤中使用化学抗原受体治疗
Elizabeth Brownlee1, Melissa Turley, Heather Nations
1In the PA program at the University of Florida in Gainesville, Fla., Elizabeth Brownlee is director of didactic education and Melissa Turley is interim program director and a clinical assistant professor. Heather Nations practices in obstetrics and gynecology at UF Health Physicians in Gainesville. The authors have disclosed no potential conflicts of interest, financial or otherwise.
概括
化学抗原受体 (CAR) T细胞疗法对血液和固体瘤有希望,提供高响应率. 然而,像细胞因子释放综合征这样的严重副作用的管理对于患者的安全和治疗成功至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
背景情况:
- 化学抗原受体 (CAR) T细胞疗法彻底改变了血液癌症的治疗方法.
- 卡尔T细胞疗法在治疗固体瘤方面显示出潜在的疗效.
- 血液性恶性瘤在CAR T细胞免疫疗法方面取得了重大进展.
研究的目的:
- 描述CAR T细胞治疗的机制和应用.
- 为初级保健提供者提供指导,管理接受CAR T细胞治疗的患者.
- 突出需要进行研究,以提高CAR T细胞治疗的安全性和有效性.
主要方法:
- 关于CAR T细胞治疗的当前文献的综述.
- 对CAR T细胞治疗结果的临床试验数据的分析.
- 对管理不良事件的专家建议的综合.
主要成果:
- 在血液恶性瘤中,CAR T细胞疗法实现了高响应率.
- 在治疗固体瘤方面,CAR T细胞治疗的潜力正在出现.
- 显著的不良反应,包括细胞因子释放综合征和神经毒性,与CAR T细胞治疗有关.
结论:
- 卡尔T细胞疗法是治疗某些癌症的强大工具.
- 对接受CAR T细胞治疗的患者来说,对副作用的仔细监测和管理至关重要.
- 需要进行进一步的研究,以优化CAR T细胞治疗的安全性和有效性,以便在更广泛的临床应用中.
相关概念视频
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.